Mesenchymal stem cell-based adjunctive therapy for Pseudomonas aeruginosa-induced keratitis: A proof-of-concept in-vitro

CONCLUSION: MSC-CM holds promise as an adjunctive therapeutic approach for P. aeruginosa-induced corneal epithelial damage.PMID:38494102 | DOI:10.1016/j.exer.2024.109863
Source: Experimental Eye Research - Category: Opthalmology Authors: Source Type: research